FBXO31 Antibody (YA7869)(PBS only)
(Synonyms: FBX14; Fbx31; FBXO14; MRT45; pp2386)FBXO31 Antibody (YA7869) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to FBXO31.
-
Host:
Mouse
-
Isotype:
IgG2b
-
Application:
ICC/IF, FC
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in PBS, pH 7.4.
-
Conjugation:
Non-conjugated
Applications
| Application |
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
FC
FC: Flow Cytometry
|
|---|---|---|
| Dilution Ratio | 1:100-250 | 1:100 |
Product Details
FBXO31 Antibody (YA7869) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to FBXO31.
-
Host Mouse
-
Species ReactivityHuman, Mouse, Rat
-
Calculated Molecular Weight Predicted band size: 60.5 kDa
Full length human recombinant protein of human FBXO31 produced in HEK293T cell.
Affinity purified
Non-conjugated
IgG2b
Product Properties
-
Appearance
Liquid
-
Formulation
Supplied in PBS, pH 7.4.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
FBXO31 is a Substrate-recognition component of the SCF(FBXO31) protein ligase complex, which specifically mediates the ubiquitination of proteins amidated at their C-terminus in response to oxidative stress, leading to their degradation by the proteasome. FBXO31 specifically recognizes and binds C-terminal peptides bearing an amide: C-terminal amidation in response to oxidative stress takes place following protein fragmentation. The SCF(FBXO31) also plays a role in G1 arrest following DNA damage by mediating ubiquitination of phosphorylated cyclin-D1 (CCND1), promoting its degradation by the proteasome, resulting in G1 arrest. The SCF(FBXO31) complex is however not a major regulator of CCND1 stability during the G1/S transition. In response to genotoxic stress, the SCF(FBXO31) complex directs ubiquitination and degradation of phosphorylated MDM2, thereby promoting p53/TP53-mediated DNA damage response. SCF(FBXO31) complex is required for genomic integrity by catalyzing ubiquitination and degradation of cyclin-A (CCNA1 and/or CCNA2) during the G1 phase. In response to genotoxic stress, the SCF(FBXO31) complex directs ubiquitination and degradation of phosphorylated FBXO46 and MAP2K6. SCF(FBXO31) complex promotes ubiquitination and degradation of CDT1 during the G2 phase to prevent re-replication. The SCF(FBXO31) complex also mediates ubiquitination and degradation of DUSP6, OGT and PARD6A[1][2][3][4][5][6][7][8][9][10][11].
-
Subcellular Localization
Cytoplasm,Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
-
Expression
Tissue_Specificity: Highly expressed in brain. Expressed at moderate levels in most tissues, except bone marrow
Induction: By DNA damage. Increases after UV irradiation, X-ray irradiation, oxidative stress (H(2)O(2)) or addition of the chemotherapeutic DNA-damaging agents etoposide, adriamycin, cisplatin or fluorouracil -
Isoforms & Post-Translational Modification
Q5XUX0 has two isomers: Q5XUX0-1: 60664 Da (predicted); Q5XUX0-2: 49039 Da (predicted).
Phosphorylation at Ser-278 by ATM following gamma-irradiation results in its stabilization (PubMed:19412162)丨Ubiquitinated by the SCF(FBXO46) complex in absence of stress, promoting its degradation (PubMed:30171069) -
Subunit
Part of a SCF (SKP1-cullin-F-box) protein ligase complex SCF(FBXO31) composed of CUL1, SKP1, RBX1 and FBXO31 (PubMed:16357137, PubMed:19412162, PubMed:31413110, PubMed:39880951)
-
SwissProt ID
-
Synonyms
FBX14; Fbx31; FBXO14; MRT45; pp2386
Documentation